Showing results 151941 to 151960 of 275604
PhaRaO: Direct Radar Odometry using Phase Correlation Park, Yeong Sang; Shin, Young-Sik; Kim, Ayoung, IEEE International Conference on Robotics and Automation, ICRA 2020, pp.2617 - 2623, Institute of Electrical and Electronics Engineers Inc., 2020-05-31 |
Pharmaceutical composition for improving, preventing or treating muscle related disease comprising ginsenoside Rh2 Yi, Gwan-Su; Li, Yi; Lee, Yoon Hyeok |
PHARMACEUTICAL COMPOSITION FOR SUPPRESSING APPETITE, CONTAINING N2-(M-TRIFLUOROBENZYL), N6-(P-NITROBENZYL)PURINE (TNP) OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF AS ACTIVE INGREDIENT Kim, Seyun; Kim, Min Seon; Kang, Gilmyoung |
PHARMACEUTICAL COMPOSITION FOR TREATING CANCER COMPRISING RNA OLIGONUCLEOTIDE 최병석; 강석조; 이장현; 민지연; 전동민; 성시은 |
Pharmaceutical composition for treating cuts Lee, Sang Yup; Yoo, Won Min; Kim, Soon Cheol; Chung, Hannah; Kim, Jiyong |
PHARMACEUTICAL COMPOSITION FOR TREATMENT OF CANCER COMPRISING RNA Choi, Byong-Seok; Kang, Suk-Jo; LEE, Janghyun; MIN, Ji Youn; CHUN, Dongmin; SUNG, Si-Eun |
PHARMACEUTICAL COMPOSITION FOR TREATMENT OF CANCER COMPRISING RNA Choi, Byong-Seok; Kang, Suk-Jo; Lee, Janghyun; Min, Ji Youn; Chun, Dongmin; Sung, Si-Eun |
PHARMACEUTICAL COMPOSITION FOR TREATMENT OF CANCER COMPRISING RNA Choi, Byong-Seok; Kang, Suk-Jo; Lee, Janghyun; Min, Ji Youn; Chun, Dongmin; Sung, Si-Eun |
PHARMACEUTICAL COMPOSITION FOR TREATMENT OF CANCER COMPRISING RNA Choi, Byong-Seok; Kang, Suk-Jo; Lee, Janghyun; Min, Ji Youn; Chun, Dongmin; Sung, Si-Eun |
PHARMACEUTICAL COMPOSITION FOR TREATMENT OF CANCER COMPRISING RNA Choi, Byong-Seok; Kang, Suk-Jo; Lee, Janghyun; Min, Ji Youn; Chun, Dongmin; Sung, Si-Eun |
PHARMACEUTICAL COMPOSITION FOR TREATMENT OF CANCER COMPRISING RNA Choi, Byong-Seok; Kang, Suk-Jo; Lee, Janghyun; Min, Ji Youn; Chun, Dongmin; Sung, Si-Eun |
Pharmaceutical composition for treatment of cancer comprising RNA oligonucleotide Choi, Byong-Seok; Kang, Suk-Jo; Lee, Janghyun; Min, Ji Youn; Chun, Dongmin; Sung, Si-Eun |
Pharmaceutical Composition for Treatment of Wounds 이상엽; 유원민; 김순철; 정해나; 김지용 |
Pharmaceutical Firms' Strategic Decisions and Patients' Welfare Dynamics Kim, Wonjoon; Paris, C; Dick, R, The Sixth Marketing Dynamics Conference, Stern School of Business, New York University, 2009-08-28 |
Pharmaceutical Firms' Strategic Decisions and Patients' Welfare Dynamics: Innovate or Imitate? Kim, Wonjoon; Paris, C; Dick, R, American Economic Association Annual Meeting 2008, American Economic Association, 2008-01-05 |
Pharmaceutical Firms' Strategic Innovation Decision Kim, Wonjoon; Paris, C; Dick, R, Korea Productivity Association Conference, Korea Productivity Association, 2011-02-11 |
Pharmacogenetics for rheumatic diseases = 류마티스 질환의 약물유전학 연구link Kim, Eun-Jin; 김은진; et al, 한국과학기술원, 2010 |
Pharmacogenomics and Single Nucleotide Polymorphisms Kang, Chang Soo; Yang, Misuk; Kang, Changwon, the 14th Annual Meeting of the Korean Society for Molecular Biology, v.0, no.0, pp.140 - 140, 2002-10-01 |
Pharmacogenomics on Anti-tumor Necrosis Factor Therapy to Rheumatoid Arthritis Kang, Changwon; Kang, Changsoo Paul; Lee, Hye-Soon; Bae, Sang-Cheol, The 61st Annual Meeting of the Korean Society for Biochemistry and Molecular Biology, v.0, no.0, pp.101 - 101, The 61st Annual Meeting of the Korean Society for Biochemistry and Molecular Biology, 2004-05-01 |
Pharmacokinetics of DA-7867, a new oxazolidinone, after intravenous or oral administration to rats: Intestinal first-pass effect Bae, SK; Chung, Won Suck; Kim, EJ; Rhee, JK; Kwon, JW; Kim, WB; Lee, MG, ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, v.48, no.2, pp.659 - 662, 2004-02 |
Discover